Caribou Biosciences, Inc. (CRBU)

NASDAQ

$0.51

$+0.04

(+9.07%)

Regular Market

Caribou Biosciences, Inc. (CRBU) Live Price Chart

Last updated: ⁦2026-10-20 16:19:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Caribou Biosciences, Inc. (CRBU) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.51, with a market capitalization of $50.38M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.44 to $3.54. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$50.38M
Open	$0.47
Day's High	$32.65
Day's Low	$0.44
Previous Close	$0.46
Volume	1.50M
Average Volume	2.44M
P/E Ratio	--
52-Week High	$3.54
52-Week Low	$0.44
Dividend Yield	--
Earnings Date	--

Caribou Biosciences, Inc. (CRBU) Stock Price Today

Caribou Biosciences, Inc. (CRBU) is currently trading at $0.51 as of 2026-10-20 16:02:09, up 9.27% ($0.04) from the previous close of $0.46

During today's regular trading session, CRBU has traded between $0.44 and $32.65, with a trading volume of 1.50M shares. The current price is near the lower end of today's range.

Caribou Biosciences, Inc. (CRBU) 7-Day Stock Price Change

Over the past seven days, Caribou Biosciences, Inc. (CRBU) moved from $0.46 to $0.51, representing a gain of 10.17% ($0.05).

The stock traded between $0.44 and $0.52 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 4.70 million shares, down versus the previous seven-day period, indicating lower trading activity.

CRBU 52-Week Price Position

Position in Range: 2.1%

52W Low$0.44

52W High$3.54

CRBU is currently trading at $0.51, placing it 2.1% of the way from its 52-week low of $0.44 to its 52-week high of $3.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Caribou Biosciences, Inc. (CRBU)?

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Caribou Biosciences, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	97
Exchange	NASDAQ
Company Website	https://www.cariboubio.com

How to Buy Caribou Biosciences, Inc. (CRBU) Stock on MEXC

Eligible investors can buy real shares of Caribou Biosciences, Inc. (CRBU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRBU and Place Your Order

Open the RealStocks trading page and search for CRBU. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Caribou Biosciences, Inc. (CRBU) stock price today?

Caribou Biosciences, Inc. (CRBU) is currently trading at $ 0.51, up 9.27% ($0.04) from the previous close of $ 0.46. Intraday prices update in real time during regular trading hours.

2.Is CRBU stock going up or down today?

As of 2026-10-20 16:02:09, CRBU is trading at $ 0.51, up 9.27% ($0.04) from its previous close of $ 0.46. The stock has traded between $ 0.44 and $ 32.65 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRBU pre-market price?

As of 2026-10-20 16:02:09, CRBU is trading at $ 0.47 in pre-market trading, up 1.94% ($0.01) from the previous close of $ 0.46. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRBU after-hours price?

As of 2026-10-20 16:02:09, CRBU is trading at $ 0.46 in after-hours trading, down 0.86% ($0.00) from the regular-session close of $ 0.46. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRBU stock trading now?

CRBU trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRBU sit relative to its 52-week high and low?

Over the past 52 weeks, CRBU has traded between a low of $ 0.44 and a high of $ 3.54. At $ 0.51, the stock is positioned 2.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Caribou Biosciences, Inc. in?

Caribou Biosciences, Inc. (CRBU) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Caribou Biosciences, Inc.'s market capitalization and where is it listed?

Caribou Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 50.38M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRBU valued in terms of P/E ratio and EPS?

CRBU trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.97. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Caribou Biosciences, Inc. pay a dividend?

Caribou Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.